XRAY (Dentsply Sirona) Beneish M-Score: -2.68 (As of Jun. 25, 2026)


XRAY Dentsply Sirona Inc XRAY
55 GF Score
Price $10.52
GF Value $19.06
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Dentsply Sirona Beneish M-Score?

Dentsply Sirona XRAY +3.14% 55 Beneish M-Score is -2.68 as of Jun. 25, 2026. GuruFocus rates XRAY with a GF Score™ of 55/100 and a GF Value™ of $19.06 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 765 Medical Devices & Instruments companies, Dentsply Sirona ranks better than 58.82% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.68 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Dentsply Sirona's Beneish M-Score or its related term are showing as below:

XRAY' s Beneish M-Score Range Over the Past 10 Years
Min: -3.11   Med: -2.62   Max: -1.77
Current: -2.68

During the past 13 years, the highest Beneish M-Score of Dentsply Sirona was -1.77. The lowest was -3.11. And the median was -2.62.


Dentsply Sirona Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Dentsply Sirona's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dentsply Sirona Beneish M-Score Chart

Dentsply Sirona Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.49 -2.78 -2.50 -3.05 -2.51

Dentsply Sirona Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.91 -2.48 -2.69 -2.51 -2.68

XRAY vs LMAT, PLSE, NNNN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Dentsply Sirona's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dentsply Sirona Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Dentsply Sirona's Beneish M-Score falls into.


XRAY
55GF Score
Dentsply Sirona Inc XRAY
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dentsply Sirona Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Dentsply Sirona for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0404+0.528 * 1.0541+0.404 * 0.8773+0.892 * 0.9898+0.115 * 1.0353
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9352+4.679 * -0.039587-0.327 * 1.1017
=-2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $622 Mil.
Revenue was 880 + 961 + 904 + 936 = $3,681 Mil.
Gross Profit was 427 + 443 + 441 + 490 = $1,801 Mil.
Total Current Assets was $1,845 Mil.
Total Assets was $5,229 Mil.
Property, Plant and Equipment(Net PPE) was $997 Mil.
Depreciation, Depletion and Amortization(DDA) was $352 Mil.
Selling, General, & Admin. Expense(SGA) was $1,432 Mil.
Total Current Liabilities was $1,207 Mil.
Long-Term Debt & Capital Lease Obligation was $2,101 Mil.
Net Income was -10 + -146 + -427 + -45 = $-628 Mil.
Non Operating Income was -48 + -150 + -253 + -238 = $-689 Mil.
Cash Flow from Operations was 40 + 101 + 79 + 48 = $268 Mil.
Total Receivables was $604 Mil.
Revenue was 879 + 905 + 951 + 984 = $3,719 Mil.
Gross Profit was 466 + 446 + 495 + 511 = $1,918 Mil.
Total Current Assets was $1,978 Mil.
Total Assets was $6,050 Mil.
Property, Plant and Equipment(Net PPE) was $924 Mil.
Depreciation, Depletion and Amortization(DDA) was $342 Mil.
Selling, General, & Admin. Expense(SGA) was $1,547 Mil.
Total Current Liabilities was $1,793 Mil.
Long-Term Debt & Capital Lease Obligation was $1,681 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(622 / 3681) / (604 / 3719)
=0.168976 / 0.162409
=1.0404

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1918 / 3719) / (1801 / 3681)
=0.51573 / 0.489269
=1.0541

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1845 + 997) / 5229) / (1 - (1978 + 924) / 6050)
=0.456493 / 0.520331
=0.8773

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3681 / 3719
=0.9898

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(342 / (342 + 924)) / (352 / (352 + 997))
=0.270142 / 0.260934
=1.0353

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1432 / 3681) / (1547 / 3719)
=0.389025 / 0.415972
=0.9352

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2101 + 1207) / 5229) / ((1681 + 1793) / 6050)
=0.632626 / 0.574215
=1.1017

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-628 - -689 - 268) / 5229
=-0.039587

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Dentsply Sirona has a M-score of -2.68 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.68 mean?
Dentsply Sirona (XRAY) has a Beneish M-Score of -2.68 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dentsply Sirona and its competitors. According to the industry distribution chart, Dentsply Sirona ranks #315 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 41.2%.
Is Dentsply Sirona's Beneish M-Score too high?
Dentsply Sirona's current Beneish M-Score is -2.68. Based on the distribution chart, Dentsply Sirona ranks #315 out of 765 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Beneish M-Score compare to LMAT and PLSE?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #315 out of 765 companies for Beneish M-Score. This puts Dentsply Sirona in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Dentsply Sirona and its competitors. Dentsply Sirona's current Beneish M-Score is -2.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $19.06, compared to a current price of $10.52 — trading 44.8% below its estimated fair value. The current Beneish M-Score is -2.68. Dentsply Sirona's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Beneish M-Score is -2.68 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dentsply Sirona (XRAY) Overvalued in 2026?

Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued. The current stock price of $10.52 is trading 44.8% below its estimated GF Value™ of $19.06. GuruFocus considers Dentsply Sirona to be Possible Value Trap.

Key valuation signals for XRAY:

  • Beneish M-Score: -2.68
  • GF Value™: $19.06 vs. price of $10.52 (44.8% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dentsply Sirona Business Description

Address 13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
55GF Score

Get the complete analysis for XRAY

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.52
Price
$19.06
GF Value